Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients.

Dennison, Jessica L; Al-Ali, Hassan; Volmar, Claude-Henry; Brothers, Shaun; Watts, Justin; Wahlestedt, Claes; Lohse, Ines

Dennison, Jessica L; Al-Ali, Hassan; Volmar, Claude-Henry; Brothers, Shaun; Watts, Justin; Wahlestedt, Claes; Lohse, Ines.

Afiliação

Dennison JL; Center for Therapeutic Innovation, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Al-Ali H; Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Volmar CH; Miami Project to Cure Paralysis, Department of Neurological Surgery, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Brothers S; Peggy and Harold Katz Family Drug Discovery Center, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Watts J; Center for Therapeutic Innovation, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Wahlestedt C; Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Lohse I; Molecular Therapeutics Shared Resource, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA.

Cancers (Basel) ; 14(17)2022 Aug 24.

Article em En | MEDLINE | ID: mdl-36077629

Palavras-chave

AML; BET inhibitors; HDAC inhibitors; drug screening; epigenetics; histone modifiers

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline / Screening_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google